CAPRICOR THERAPEUTICS, INC. (CAPR) › RevenueCAPRICOR THERAPEUTICS, INC. (CAPR) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $1.35M2013: $503.2K2014: $4.79M2015: $5.52M2016: $4.00M2017: $2.67M2018: $1.67M2019: $1.01M2020: $310.2K2021: $244.9K2022: $2.55M2023: $25.18M2024: $22.27M2025: $0$02011Revenue (USD)2025Fiscal YearRevenueChange YoY2025$0-100.0%2024$22.27M-11.5%2023$25.18M+886.8%2022$2.55M+941.8%2021$244.9K-21.1%2020$310.2K-69.1%2019$1.01M-39.9%2018$1.67M-37.3%2017$2.67M-33.3%2016$4.00M-27.5%2015$5.52M+15.3%2014$4.79M+851.2%2013$503.2K—2011$1.35M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share